Completed PHASE3 INTERVENTIONAL 2-arm NCT01497951

Photodynamic Therapy for Oral Precursor Lesions (PDT)

A Randomized Controlled Trial: Photodynamic Treatment for the Therapy of Premalignant Mucosal Oral Lesions.

Sponsor: Medical University of Vienna

Interventions Aminolaevulinic acid Methylcellulose Placebo

Updated 6 times since 2017 Last updated: May 16, 2017 Started: May 31, 2011 Primary completion: Jan 31, 2017 Completion: Jan 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Leukoplakia and Lichen and is currently completed. Medical University of Vienna leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jun 2017 — Jun 2018 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Recruiting PHASE3

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Vienna

Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria